Literature DB >> 26841865

PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/β-Catenin Pathway.

Zlata Vershinin1, Michal Feldman1, Ayelet Chen1, Dan Levy2.   

Abstract

Lysine methylation of non-histone proteins has emerged as a key regulator of many cellular functions. Although less studied than other post-translational modifications such as phosphorylation and acetylation, the number of known methylated non-histone proteins is rapidly expanding. We have identified the p21-activated kinase 4 (PAK4) as a new substrate for methylation by the protein lysine methyltransferase SETD6. Our data demonstrate that SETD6 methylates PAK4 bothin vitroand at chromatin in cells. Interestingly, depletion of SETD6 in various cellular systems significantly hinders the activation of the Wnt/β-catenin target genes. PAK4 was recently shown to regulate β-catenin signaling, and we show that SETD6 is a key mediator of this pathway. In the presence of SETD6, the physical interaction between PAK4 and β-catenin is dramatically increased, leading to a significant increase in the transcription of β-catenin target genes. Taken together, our results uncover a new regulatory layer of the Wnt/β-catenin signaling cascade and provide new insight into SETD6 biology.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  PAK4; S-adenosylmethionine (SAM); SETD6; Wnt pathway; Wnt signaling; chromatin; gene transcription; methylation; post-translational modification (PTM); β-catenin (β-catenin)

Mesh:

Substances:

Year:  2016        PMID: 26841865      PMCID: PMC4807267          DOI: 10.1074/jbc.M115.697292

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  SET7/9 regulates cancer cell proliferation by influencing β-catenin stability.

Authors:  Changchun Shen; Donglai Wang; Xiangyu Liu; Bo Gu; Yipeng Du; Fu-Zheng Wei; Lin-Lin Cao; Boyan Song; Xiaopeng Lu; Qiaoyan Yang; Qian Zhu; Tianyun Hou; Meiting Li; Lina Wang; Haiying Wang; Ying Zhao; Yang Yang; Wei-Guo Zhu
Journal:  FASEB J       Date:  2015-06-26       Impact factor: 5.191

2.  Group I and II mammalian PAKs have different modes of activation by Cdc42.

Authors:  Yohendran Baskaran; Yuen-Wai Ng; Widyawilis Selamat; Felicia Tay Pei Ling; Ed Manser
Journal:  EMBO Rep       Date:  2012-06-29       Impact factor: 8.807

3.  PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia.

Authors:  A Abo; J Qu; M S Cammarano; C Dan; A Fritsch; V Baud; B Belisle; A Minden
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

4.  A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor.

Authors:  Guizhong Liu; Anna Bafico; Violaine K Harris; Stuart A Aaronson
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

5.  Modulation of p53 function by SET8-mediated methylation at lysine 382.

Authors:  Xiaobing Shi; Ioulia Kachirskaia; Hiroshi Yamaguchi; Lisandra E West; Hong Wen; Evelyn W Wang; Sucharita Dutta; Ettore Appella; Or Gozani
Journal:  Mol Cell       Date:  2007-08-17       Impact factor: 17.970

6.  A proteomic approach for the identification of novel lysine methyltransferase substrates.

Authors:  Dan Levy; Chih Long Liu; Ze Yang; Aaron M Newman; Ash A Alizadeh; Paul J Utz; Or Gozani
Journal:  Epigenetics Chromatin       Date:  2011-10-24       Impact factor: 4.954

7.  The Cdc42 Effector Kinase PAK4 Localizes to Cell-Cell Junctions and Contributes to Establishing Cell Polarity.

Authors:  Widyawilis Selamat; Pei-Ling Felicia Tay; Yohendran Baskaran; Ed Manser
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

8.  Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.

Authors:  Ailan Guo; Hongbo Gu; Jing Zhou; Daniel Mulhern; Yi Wang; Kimberly A Lee; Vicky Yang; Mike Aguiar; Jon Kornhauser; Xiaoying Jia; Jianmin Ren; Sean A Beausoleil; Jeffrey C Silva; Vidyasiri Vemulapalli; Mark T Bedford; Michael J Comb
Journal:  Mol Cell Proteomics       Date:  2013-10-15       Impact factor: 5.911

9.  SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells.

Authors:  Daniel J O'Neill; Stuart Charles Williamson; Dhuha Alkharaif; Isabella Christina Mazzaro Monteiro; Marilyn Goudreault; Luke Gaughan; Craig N Robson; Anne-Claude Gingras; Olivier Binda
Journal:  Epigenetics       Date:  2014-04-21       Impact factor: 4.528

10.  Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling.

Authors:  Andreas Herbst; Vindi Jurinovic; Stefan Krebs; Susanne E Thieme; Helmut Blum; Burkhard Göke; Frank T Kolligs
Journal:  BMC Genomics       Date:  2014-01-28       Impact factor: 3.969

View more
  21 in total

1.  The methyltransferase SETD6 regulates Mitotic progression through PLK1 methylation.

Authors:  Michal Feldman; Zlata Vershinin; Inna Goliand; Natalie Elia; Dan Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-08       Impact factor: 11.205

2.  Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.

Authors:  Xiaoqing Cheng; Yuan Hao; Wenjie Shu; Mengjie Zhao; Chen Zhao; Yuan Wu; Xiaodan Peng; Pinfang Yao; Daibiao Xiao; Guoliang Qing; Zhengying Pan; Lei Yin; Desheng Hu; Hai-Ning Du
Journal:  J Biol Chem       Date:  2017-04-25       Impact factor: 5.157

Review 3.  Structure, biochemistry, and biology of PAK kinases.

Authors:  Rakesh Kumar; Rahul Sanawar; Xiaodong Li; Feng Li
Journal:  Gene       Date:  2016-12-19       Impact factor: 3.688

4.  Deletion of Mouse Setd4 Promotes the Recovery of Hematopoietic Failure.

Authors:  Xing Feng; Huimei Lu; Jingyin Yue; Megha Shettigar; Jingmei Liu; Lisa K Denzin; Zhiyuan Shen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-04       Impact factor: 7.038

5.  Loss of Setd4 delays radiation-induced thymic lymphoma in mice.

Authors:  Xing Feng; Huimei Lu; Jingyin Yue; Neta Schneider; Jingmei Liu; Lisa K Denzin; Chang S Chan; Subhajyoti De; Zhiyuan Shen
Journal:  DNA Repair (Amst)       Date:  2019-11-25

6.  Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA.

Authors:  Wentao Huang; Hongjing Liu; Tianzhu Lv
Journal:  Histol Histopathol       Date:  2021-03-12       Impact factor: 2.303

7.  Arginine and lysine methylation of MRPS23 promotes breast cancer metastasis through regulating OXPHOS.

Authors:  Lingxia Liu; Xiliu Zhang; Huayi Ding; Xin Liu; Donghui Cao; Yingqi Liu; Jiwei Liu; Cong Lin; Na Zhang; Guannan Wang; Jingyao Hou; Baiqu Huang; Yu Zhang; Jun Lu
Journal:  Oncogene       Date:  2021-04-29       Impact factor: 9.867

8.  CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway.

Authors:  Chuntian Huang; Ruijuan Du; Xuechao Jia; Kangdong Liu; Yan Qiao; Qiong Wu; Ning Yao; Lu Yang; Liting Zhou; Xuejiao Liu; Pu Xiang; Mingxia Xin; Yan Wang; Xiaojie Chen; Dong Joon Kim; Zigang Dong; Xiang Li
Journal:  Cell Death Differ       Date:  2021-07-14       Impact factor: 15.828

9.  PAK4 inhibition improves PD-1 blockade immunotherapy.

Authors:  Catherine S Grasso; Antoni Ribas; Gabriel Abril-Rodriguez; Davis Y Torrejon; Wei Liu; Jesse M Zaretsky; Theodore S Nowicki; Jennifer Tsoi; Cristina Puig-Saus; Ignacio Baselga-Carretero; Egmidio Medina; Michael J Quist; Alejandro J Garcia; William Senapedis; Erkan Baloglu; Anusha Kalbasi; Gardenia Cheung-Lau; Beata Berent-Maoz; Begoña Comin-Anduix; Siwen Hu-Lieskovan; Cun-Yu Wang
Journal:  Nat Cancer       Date:  2019-12-09

10.  BRD4 methylation by the methyltransferase SETD6 regulates selective transcription to control mRNA translation.

Authors:  Zlata Vershinin; Michal Feldman; Thilo Werner; Lital Estrella Weil; Margarita Kublanovsky; Elina Abaev-Schneiderman; Menachem Sklarz; Enid Y N Lam; Khawla Alasad; Sarah Picaud; Barak Rotblat; Ruth A McAdam; Vered Chalifa-Caspi; Marcus Bantscheff; Trevor Chapman; Huw D Lewis; Panagis Filippakopoulos; Mark A Dawson; Paola Grandi; Rab K Prinjha; Dan Levy
Journal:  Sci Adv       Date:  2021-05-26       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.